Or the 50 something plumber sells out, has his non-pension/401(k) retirement nest egg secure, and continues as an employee at a more relaxed pace for a few more years.
OT: Stock and Investment Talk
- Thread starter RU-05
- Start date
Or the 50 something plumber sells out, has his non-pension/401(k) retirement nest egg secure, and continues as an employee at a more relaxed pace for a few more years.
My goodness, this has to be the mega-meme of all-time. Someone must have been hunting for a tiny micro-cap stock to push.NUKK is up 4700% in 2 days. In one month went from $1.30 to over $70. Makes GME look like a joke.
A tiny fintech stock is up 4,700% in 2 days after taking a stake in a company involved with Israel's Iron Dome missile system
Fintech firm Nukkleus saw its market cap jump from about $3 million to $125 million in just two days.markets.businessinsider.com
The only commentary that matters:
TOM LEE = This is a "buy the dip" moment, maybe more like “back up the truck”
😁
This was a good post-crash day. We ended pretty much flat. Everyone gets to take a breath and realize the economy and earnings are strong.
Looks like most of it has evaporated in the after hours. That’s the volatility of extended trading off earnings lol.
Don’t know if they’ve given or will give guidance. He should kitchen sink it all this qtr and start fresh and reset.
I wouldn’t expect much of a rally until they can demonstrate a baselining in their decline of share and return to growth. It’s going to take a little bit of time for that, if and when it happens.
Bought some BA and JBLU.
Both charts look like they are ready to get out of the mud. Moreso BA.
Both charts look like they are ready to get out of the mud. Moreso BA.
I'll listen to their call later tonight. Last quarter seemed like a kitchen sink report, so maybe this one is less bad. LOL!
LLY just mentioned on Fast Money…Zepbound no longer on the shortage list so compounding will be stopped March of next year.
Weight loss behemoths LLY and NVO been shedding some pounds themselves lately, both around 25% off the highs.
Weight loss behemoths LLY and NVO been shedding some pounds themselves lately, both around 25% off the highs.
Don’t normally care for Dan Nathan but on the final trade for FM he said I’d wait to see a 6 handle on NKE before getting in and I kind of agree with that and waiting to see if it happens.
Mike Khouw’s final trade was UNH despite the PBM and headline risks. Lebanthal (don’t care for him either)also owns UNH he mentioned on halftime.
I only started with a 1/2 position, so can add if it dips below $70. UNH is an interesting play that I would be happy to jump back into. As of now, the PBM stuff is all talk and FUD. It may become reality but more likely it will fizzle out like most DC big ideas.
No. "Shutdowns" are complete BS with about 95% of the gov'ment functioning completely normal. All that matters tomorrow is the new PCE report.
And looks like NVO will shed a few more pounds. Down 20% in the premarket on obesity drug trial results
LLY up 10% in the premarket, I assume off this news…was a little surprised it was red yesterday after the compounding news.
Last edited:
NKE down 7% in the premarket…quite the reversal from the initial after hours lol.
A bunch of downward revisions to price targets.
If it pushes a little deeper into the mid 60s, I’d step in there. Not a quick turnaround story here though. That never bothers me though as long as it does turn eventually lol.
A bunch of downward revisions to price targets.
If it pushes a little deeper into the mid 60s, I’d step in there. Not a quick turnaround story here though. That never bothers me though as long as it does turn eventually lol.
Yeah! Soft PCE print today.
The core PCE Price Index, the Federal Reserve's preferred inflation measure, edged up 0.1% M/M in November, less than the +0.2% consensus and cooling from the +0.3% pace in October. Personal income and spending also came in slightly lower than expected in the month.
On a year-over-year basis, core PCE increased 2.8%, just under the 2.9% consensus and running at the same pace as in October.
PCE Price Index, which includes food and energy, also ticked up 0.1% M/M vs. +0.2% consensus and +0.2% prior. That measure translated to a 2.4% Y/Y increase, less than the +2.5% consensus, but slightly hotter than the 2.3% rise in October.
Personal income: +0.3% M/M vs. +0.4% expected and +0.6% prior.
Personal outlays: +0.4% M/M vs. +0.5% consensus and +0.4% prior.
The core PCE Price Index, the Federal Reserve's preferred inflation measure, edged up 0.1% M/M in November, less than the +0.2% consensus and cooling from the +0.3% pace in October. Personal income and spending also came in slightly lower than expected in the month.
On a year-over-year basis, core PCE increased 2.8%, just under the 2.9% consensus and running at the same pace as in October.
PCE Price Index, which includes food and energy, also ticked up 0.1% M/M vs. +0.2% consensus and +0.2% prior. That measure translated to a 2.4% Y/Y increase, less than the +2.5% consensus, but slightly hotter than the 2.3% rise in October.
Personal income: +0.3% M/M vs. +0.4% expected and +0.6% prior.
Personal outlays: +0.4% M/M vs. +0.5% consensus and +0.4% prior.
My Viking/VKTX also up 10% on the news. One of my small cap biotech plays.
Yes I’ve read about that one but not one for me. Could be a takeout target down the line. I think AMGN is another one that supposedly good or will be good in this area. That’s more my tolerance.
The NVO news seems like an overreaction. 22.7 vs 25% is that big a deal to tank the stock 20+%? Those results still seem as good as or better than the LLY drugs. Side effects no different that the other drugs too. Seems like something else should be a problem for this big a hit. It’s almost 50% off the highs now. It’s on watch for me and if it goes deeper into to the 70s might step in there as well. Current overall market sentiment could take it lower too.
There is another trial going on for its combo treatment as well, those results will come out next year.
Yes, small-cap/clinical-stage biotech is f'ing wild. But hey, this is what I have been doing for the past 4 years (instead of big pharma), so when in Rome.....
These pre-revenue biotechs are literally strikeout (going to $0) or grand slam (25-50x or even more). I currently own 6 in a small custom stock basket. Just need one to hit. Good times. LOL!
Yea, HUMA is up 78% today on FDA approval of their vascular conduit for repair of severe arterial injury. Big step since its been used in the Ukraine war for awhile now.
Just saw! HUMA is ripping. My biotech basket is super green this morning. :)
Overall great news for patients and the company.
He also made a big SiriusXM purchase. Other than maybe a billboard here and there, I rarely hear of them anymore. I don’t know anyone who has it, yet he’s buying it regularly.
Not that anecdotal evidence is a way to evaluate stocks, but just look at the Nike line of sneakers compared to ON, Hoka, etc. It reminds of UnderArmour when it crashed and burned. Although the Nike brand is so strong that it will make a comeback at some point.
If I only knew…
Price Club employee while still a student in the 80s. Decided on their 401(k) than the stock. They matched too.
401(k) was great, especially when the City offered one and I rolled it over.
But still should have bought then.
This is what I am counting on. They signed Caitlyn Clark, so they have the most marketable athlete in the US right now. Get her shoe out ASAP! :)
I’m a regular brisk walker as part of my exercise and just bought a pair of Hoka Bondis to see what the hype was about and can’t say that I’m impressed. I was somewhat hesitant because I had bought Adidas Ultraboost in the past and I didn’t like them, so was like are these going to be similar after paying a premium. I think they’re better than the Ultraboost but nothing special to pay any big premium over a “normal” sneaker. When these wear out I’ll go back to the “normal” sneakers.
But regardless of my personal experience, they are the trend and I do keep a watch on ONON and DECK to see how they’re performing. They have taken share away from NKE domestically (I think in part because NKE pulled away from wholesale retailers, a move they’re trying to reverse now) and they face similar domestic competitors in China. It’s still NKE and at some point it represents good value, eventually it’ll plateau and then comps will be easier too.
I tortured myself one day and did some research.
It was enlightening to say the least. LOL
You’re right but easier said than done as we’re all human…coulda shoulda woulda is hard to completely get out of your head
True.
But like @rutgersguy1 said, easier said than done.
My late Dad learned/studied the market while having the same career as me. Ended up on the water in Sea Girt and a gated community in Naples.
I disagree. Absolutely look back because then when you're hesitant to make your next purchase/play you can think, "In 20 years will I have regretted not buying this stock?"
Very fair and reasonable POV. If you are active with the markets, it's pretty much impossible not to see former stocks from time to time.
Wore Nikes forever but now I primarily wear Hoka and ON. My son only wears Ultraboosts. Nike has done such a terrible job with product design it’s hard to believe they sat still watching their market share shrink YOY. I suspect it won’t be long before they put out the new “it” shoe
Similar threads
